Oklahoma Code § 63-427.17v2

Title 63. Public Health And Safety: Medical marijuana testing laboratory license –
Open in Lexace · Ask the AI about this section
Requirements.
A.  There is hereby created a medical marijuana testing
laboratory license as a category of the medical marijuana business
license.  The Oklahoma Medical Marijuana Authority, the Oklahoma
State Bureau of Narcotics and Dangerous Drugs Control, the Oklahoma
State Bureau of Investigation, and the Attorney General are hereby
enabled to monitor, inspect and audit a licensed testing laboratory
under the Oklahoma Medical Marijuana and Patient Protection Act.

B.  The Authority is hereby authorized to operate a quality
assurance laboratory or to contract with a private laboratory for
the purpose of conducting compliance testing of medical marijuana
testing laboratories licensed in this state.  Any such laboratory
under contract for compliance testing shall be prohibited from
conducting any other commercial medical marijuana testing in this
state.  If the Authority contracts with a private laboratory to
implement the requirements of this section:
1.  The laboratory shall not employ, or be owned by, the
following:
a. any individual that has a direct or indirect interest
in a licensed medical marijuana business, or
b. any individual or his or her spouse, parent, child,
spouse of a child, sibling or spouse of a sibling that
has an application for a medical marijuana business
license pending before the Authority or is a member of
the board of directors of a medical marijuana
business, or is an individual financially interested
in any licensee or medical marijuana business located
within this state; and
2.  The laboratory and a board or committee comprised of
licensed Oklahoma medical marijuana laboratories currently
accredited by the International Organization for Standardization
(ISO) shall provide to the Authority its recommendations for all
equipment and standards to be utilized by licensed medical marijuana
testing laboratories when testing samples of medical marijuana,
medical marijuana concentrate, and medical marijuana products as
well as standard operating procedures when extracting and testing
medical marijuana, medical marijuana concentrate, and medical
marijuana products.  The recommendations shall be submitted to the
Authority no later than June 1, 2023.  The Authority shall have
ninety (90) days from the date it receives the recommendations to
promulgate new rules or modify its current rules for laboratory
standards and testing.  Beginning June 1, 2024, medical marijuana
testing laboratories renewing their medical marijuana business
license shall be subject to and comply with any new or modified
rules relating to the testing of medical marijuana, medical
marijuana concentrate, and medical marijuana products.  The refusal
or failure of a medical marijuana testing laboratory licensee to
comply with new or modified rules relating to laboratory standards
and testing procedures promulgated under the provisions of this
paragraph shall result in the permanent revocation of the medical
marijuana testing laboratory license.
C.  The Authority shall develop acceptable testing practices
including, but not limited to, testing, standards, quality control
analysis, equipment certification and calibration, and chemical
identification and substances used.

D.  A person who is a direct beneficial owner of a medical
marijuana dispensary, medical marijuana commercial grower or medical
marijuana processor shall not be an owner of a laboratory.
E.  A laboratory and a laboratory applicant shall comply with
all applicable local ordinances including, but not limited to,
zoning, occupancy, licensing and building codes.
F.  A separate license shall be required for each specific
laboratory.
G.  A medical marijuana testing laboratory license may be issued
to a person who performs testing on medical marijuana and medical
marijuana products for medical marijuana businesses, medical
marijuana research facilities, medical marijuana education
facilities, and testing on marijuana and marijuana products grown or
produced by a patient or caregiver on behalf of a patient, upon
verification of registration.  A medical marijuana testing
laboratory may also conduct research related to the development and
improvement of its testing practices and procedures.  No state-
approved medical marijuana testing facility shall operate unless a
medical laboratory director is on site during operational hours.
H.  Laboratory applicants and licensees shall comply with the
application requirements of this section and shall submit such other
information as required for a medical marijuana business applicant,
in addition to any information the Authority may request for initial
approval and periodic evaluations during the approval period.
I.  A medical marijuana testing laboratory may accept samples of
medical marijuana, medical marijuana concentrate or medical
marijuana product from a medical marijuana business, medical
marijuana research facility or medical marijuana education facility
for testing purposes only, which purposes may include the provision
of testing services for samples submitted by a medical marijuana
business for product development.  The Authority may require a
medical marijuana business to submit a sample of medical marijuana,
medical marijuana concentrate or medical marijuana product to a
medical marijuana testing or quality assurance laboratory upon
demand.
J.  A medical marijuana testing laboratory may accept samples of
medical marijuana, medical marijuana concentrate or medical
marijuana product from an individual person for testing only under
the following conditions:
1.  The individual person is a patient or caregiver pursuant to
the Oklahoma Medical Marijuana and Patient Protection Act or is a
participant in an approved clinical or observational study conducted
by a research facility; and
2.  The medical marijuana testing laboratory shall require the
patient or caregiver to produce a valid patient license and current
and valid photo identification.

K.  A medical marijuana testing laboratory may transfer samples
to another medical marijuana testing laboratory for testing.  All
laboratory reports provided to or by a medical marijuana business or
to a patient or caregiver shall identify the medical marijuana
testing laboratory that actually conducted the test.
L.  A medical marijuana testing laboratory may utilize a
licensed medical marijuana transporter to transport samples of
medical marijuana, medical marijuana concentrate and medical
marijuana product for testing, in accordance with the Oklahoma
Medical Marijuana and Patient Protection Act and the rules adopted
pursuant thereto, between the originating medical marijuana business
requesting testing services and the destination laboratory
performing testing services.
M.  The medical marijuana testing laboratory shall establish
policies to prevent the existence of or appearance of undue
commercial, financial or other influences that may diminish the
competency, impartiality and integrity of the testing processes or
results of the laboratory, or that may diminish public confidence in
the competency, impartiality and integrity of the testing processes
or results of the laboratory.  At a minimum, employees, owners or
agents of a medical marijuana testing laboratory who participate in
any aspect of the analysis and results of a sample are prohibited
from improperly influencing the testing process, improperly
manipulating data or improperly benefiting from any ongoing
financial, employment, personal or business relationship with the
medical marijuana business that provided the sample.  A medical
marijuana testing laboratory shall not test samples for any medical
marijuana business in which an owner, employee or agent of the
medical marijuana testing laboratory has any form of ownership or
financial interest in the medical marijuana business.
N.  The Authority, pursuant to rules promulgated by the
Executive Director of the Authority, shall develop standards,
policies and procedures as necessary for:
1.  The cleanliness and orderliness of a laboratory premises and
the location of the laboratory in a secure location, and inspection,
cleaning and maintenance of any equipment or utensils used for the
analysis of test samples;
2.  Testing procedures, testing standards for cannabinoid and
terpenoid potency and safe levels of contaminants, and remediation
procedures;
3.  Controlled access areas for storage of medical marijuana and
medical marijuana product test samples, waste and reference
standards;
4.  Records to be retained and computer systems to be utilized
by the laboratory;
5.  The possession, storage and use by the laboratory of
reagents, solutions and reference standards;

6.  A certificate of analysis (COA) for each lot of reference
standard;
7.  The transport and disposal of unused marijuana, marijuana
products and waste;
8.  The mandatory use by a laboratory of an inventory tracking
system to ensure all harvest and production batches or samples
containing medical marijuana, medical marijuana concentrate or
medical marijuana products are identified and tracked from the point
they are transferred from a medical marijuana business, a patient or
a caregiver through the point of transfer, destruction or disposal.
The inventory tracking system reporting shall include the results of
any tests that are conducted on medical marijuana, medical marijuana
concentrate or medical marijuana product;
9.  Standards of performance;
10.  The employment of laboratory personnel;
11.  A written standard operating procedure manual to be
maintained and updated by the laboratory;
12.  The successful participation in a proficiency testing
program approved by the Executive Director for each testing category
listed in this section, in order to obtain and maintain
certification;
13.  The establishment of and adherence to a quality assurance
and quality control program to ensure sufficient monitoring of
laboratory processes and quality of results reported;
14.  The immediate recall of medical marijuana or medical
marijuana products that test above allowable thresholds or are
otherwise determined to be unsafe;
15.  The establishment by the laboratory of a system to document
the complete chain of custody for samples from receipt through
disposal;
16.  The establishment by the laboratory of a system to retain
and maintain all required records, including business records, and
processes to ensure results are reported in a timely and accurate
manner; and
17.  Any other aspect of laboratory testing of medical marijuana
or medical marijuana product deemed necessary by the Executive
Director.
O.  A medical marijuana testing laboratory shall promptly
provide the Authority or designee of the Authority access to a
report of a test and any underlying data that is conducted on a
sample at the request of a medical marijuana business or qualified
patient.  A medical marijuana testing laboratory shall also provide
access to the Authority or designee of the Authority to laboratory
premises and to any material or information requested by the
Authority to determine compliance with the requirements of this
section.

P.  A medical marijuana testing laboratory shall retain all
results of laboratory tests conducted on marijuana or products for a
period of at least seven (7) years and shall make them available to
the Authority upon request.
Q.  A medical marijuana testing laboratory shall test samples
from each final product harvest batch or final product batch, as
appropriate, of medical marijuana, medical marijuana concentrate and
medical marijuana product for each of the following categories of
testing, consistent with standards developed by the Executive
Director:
1.  Microbials;
2.  Mycotoxins;
3.  Residual solvents;
4.  Pesticides;
5.  Tetrahydrocannabinol (THC) and other cannabinoid potency;
6.  Terpenoid type and concentration; and
7.  Heavy metals.
R.  A licensed medical marijuana testing laboratory shall test
each final product batch.  A grower shall separate each harvest of
usable marijuana into final harvest batches containing no more than
fifteen (15) pounds, with the exception of any plant material to be
sold to a licensed processor for the purposes of turning the plant
material into concentrate which may be separated into final harvest
batches of no more than fifty (50) pounds.  A processor shall
separate each medical marijuana production lot into final production
batches containing no more than four (4) liters of concentrate or
nine (9) pounds for nonliquid products, and for final edible
products, the Oklahoma Medical Marijuana Authority shall be
authorized to promulgate rules on final products as necessary.
Provided, however, the Authority shall not require testing of final
products less often than every one thousand (1,000) grams of THC.
As used in this subsection, “final edible products” shall include,
but not be limited to, cookies, brownies, candies, gummies,
beverages and chocolates.
S.  Medical marijuana testing laboratory licensure shall be
contingent upon successful on-site inspection, successful
participation in proficiency testing and ongoing compliance with the
applicable requirements in this section.
T.  A medical marijuana testing laboratory shall be inspected
prior to initial licensure and up to two (2) times per year
thereafter by an inspector approved by the Authority.  The Authority
may enter the licensed premises of a testing laboratory to conduct
investigations and additional inspections when the Authority
believes an investigation or additional inspection is necessary due
to a possible violation of applicable laws, rules or regulations.
U.  Medical marijuana testing laboratories shall obtain
accreditation by an accrediting body approved by the Executive

Director or the Authority's quality assurance laboratory within one
(1) year of the date the initial license is issued.  Renewal of any
medical marijuana testing laboratory license shall be contingent
upon accreditation in accordance with this subsection.  All medical
marijuana testing laboratories shall obtain accreditation prior to
applying for and receiving a medical marijuana testing laboratory
license.
V.  Unless authorized by the provisions of this section, a
commercial grower shall not transfer or sell medical marijuana and a
processor shall not transfer, sell or process into a concentrate or
product any medical marijuana, medical marijuana concentrate or
medical marijuana product unless samples from each final harvest
batch or final production batch from which that medical marijuana,
medical marijuana concentrate or medical marijuana product was
derived has been tested by a medical marijuana testing laboratory
and passed all contaminant tests required by the Oklahoma Medical
Marijuana and Patient Protection Act and applicable laws, rules and
regulations.  A licensed commercial grower may transfer medical
marijuana that has failed testing to a licensed processor in
accordance with the provisions of the Oklahoma Medical Marijuana and
Patient Protection Act and the rules and regulations promulgated by
the Executive Director.
W.  Kief shall not be transferred or sold except as authorized
in the rules and regulations promulgated by the Executive Director.
X.  A licensed commercial grower or licensed processor shall not
transfer any product to a licensed medical marijuana dispensary
until the product has undergone final product testing.  Laboratory
testing that meets all contaminant tests and applicable laws, rules,
and regulations required by the Oklahoma Medical Marijuana and
Patient Protection Act shall only be required when the final product
is completed and prior to transfer to a licensed medical marijuana
dispensary, licensed medical marijuana patient, or licensed medical
marijuana caregiver.
Added by Laws 2019, c. 11, § 17. Amended by Laws 2019, c. 312, § 4,
emerg. eff. May 7, 2019; Laws 2021, c. 553, § 19, eff. Nov. 1, 2021;
Laws 2022, c. 251, § 17, eff. Nov. 1, 2022; Laws 2022, c. 353, § 1,
emerg. eff. May 26, 2022; Laws 2023, c. 168, § 8, eff. Nov. 1, 2023;
Laws 2023, c. 322, § 9, emerg. eff. June 1, 2023; Laws 2024, c. 447,
§ 4, emerg. eff. June 14, 2024.
NOTE:  Laws 2023, c. 322, § 9 was purportedly repealed by Laws 2024,
c. 452, § 143 but without reference to Laws 2024, c. 447, § 4, which
amended it.

‹ Prev All Oklahoma sections Next ›


Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.